Videos
ADAP Advocacy issued the following videos:
ADAP Advocacy issued the following videos:
The 340B Drug Pricing Program, a federal program designed to help poor patients access affordable healthcare, should literally be the glue holding the American healthcare system together.
ADAP Advocacy released its new Public Service Announcement on the current funding crisis facing the AIDS Drug Assistance Programs (ADAPs), which has led to ADAP waiting lists impacting 2 states and over 1,000 patients living with HIV/AIDS. The new PSA builds on the landmark PSA – which was first released in 2011 during the previous ADAP Crisis.
The 340B Drug Pricing Program has a dirty little secret: drug manufacturer rebates intended to help poor patients access healthcare services are being used to fund excessive compensation for hospital CEOs. This program was designed to help patients, not pad the pockets of healthcare executives.
The 340B Drug Pricing Program has a dirty little secret: drug manufacturer rebates intended to help poor patients access healthcare services are being used to fund excessive compensation for hospital CEOs. This program was designed to help patients, not pad the pockets of healthcare executives.
The 340B Drug Pricing Program was designed to help poor patients access healthcare services. Yet, despite this program growing to $66 billion, primarily benefiting hospitals, medical debt continues to be a crippling financial burden for many Americans, with most of the debt being owed to these 340B-eligible hospitals.
The 340B Drug Pricing Program was designed to help poor patients access healthcare services. Yet, despite this program growing to $66 billion, primarily benefiting hospitals, medical debt continues to be a crippling financial burden for many Americans, with most of the debt being owed to these 340B-eligible hospitals.
In 2008, we wondered if the financial bubble would burst as financial institutions deemed “too big to fail” teetered during a global economic crisis. Today, we watch the same thing happen to healthcare—particularly the 340B Drug Pricing Program.
Brandon M. Macsata, CEO of the ADAP Advocacy Association and a long-term survivor living with HIV, shares some important steps patients can take to combat counterfeit drugs.
#YourVaccineIsWaiting - Michelle Anderson, community activist and policy associate living with HIV, shares why she decided to get vaccinated against Covid-19.
#YourVaccineIsWaiting - Tez Anderson, a long-term survivor living with HIV, shares why he decided to get vaccinated against Covid-19.